1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow bucillamine: new trials by email Literature Review of bucillamine trials Research Report on bucillamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bucillamine in Treatment of Patients With COVID-19 Bucillamine, Placebo - Covid19 | Phase 3 | Terminated | Revive Therapeutics, Ltd. | 713 | 2020-11-27 | 2023-07-07 |
| A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA) Sarilumab, Sulfasalazine, Leflunomide - Rheumatoid Arthritis | Phase 3 | Completed | Sanofi | 91 | 2015-02-01 | 2018-01-30 |
Arthritis, Rheumatoid (1) · COVID-19 (1)
Revive Therapeutics, Ltd. (1) · Sanofi (1)
Japan (1) · Puerto Rico (1) · United States (1)